Hims and Hers Health Inc vs Williams Companies Inc — how do they compare? Hims and Hers Health Inc trades at $32.7 (market cap $7.57B), while Williams Companies Inc trades at $73.25 (market cap $90.70B). The key difference: Williams Companies Inc is far larger — about 12× Hims and Hers Health Inc's market cap, and Williams Companies Inc pays a 2.83% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| HIMS | WMB | |
|---|---|---|
Market Cap | $7.57B | $90.70B |
Sector | Health | Energy |
52-Week High | $66.18 | $79.40 |
52-Week Low | $14.52 | $56.51 |
Enterprise Value | $7.95B | $120.08B |
Dividend Yield | — | 2.83% |
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a mixed technical picture showing bullish moving averages but neutral oscillators. Fundamentally, the company reported 2025 revenue of $2.35 billion and net income of $128.37 million, though 2026 projections indicate a net loss. Recent news highlights executive departures and anticipation for Q2 2026 earnings on August 10, 2026.
The investment outlook is cautiously optimistic, supported by a 35% analyst buy rating and a $33.57 consensus price target. Key opportunities include growth in the weight-loss drug segment and international expansion. Risks involve profitability volatility, intense competition, and reliance on telehealth regulatory frameworks. The stock's valuation remains elevated with a P/E of 57.14, demanding strong future earnings growth to justify current levels.
Williams Companies (WMB) trades at $73.36, showing minimal daily movement with a slight 0.03% decline. The stock demonstrates strong profitability with 23.4% net income margins and 21.95% ROE, though valuation metrics appear elevated with a P/E of 32.53. Recent developments include a $5.34 billion Blackstone-led investment for power innovation projects and potential $5.5 billion Momentum Midstream acquisition, positioning the company for strategic growth in energy infrastructure.
WMB presents a compelling investment case with strong analyst support (79% buy ratings) and $86 consensus price target representing 17% upside. The company's fee-based midstream model provides revenue stability, while recent strategic investments enhance growth prospects. Key risks include commodity price volatility, execution challenges from major acquisitions, and elevated debt levels at 52% of assets.
Trailing returns across standard periods
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →